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INTRODUCTION
Blood product use during coronary artery bypass
grafting is an easy solution to the large volume of blood
loss; however, there is growing evidence that this is
associated with other complications as well.1-6 Current
transfusion trends for packed red blood cells average
between 0 to 6.3 units per person.1,2 This variation in
transfusion rate exists due to a host of factors which
range from preexisting comorbidities to use of anti-
platelet agents, procedure related factors, and even
institution-based variability.7
It would be correct to extrapolate from pre-existing
European, North American and Middle Eastern data that
a decrease in transfusion rate will assist in conserving
resources and improving outcomes by controlling
complications, some of which stem directly from
transfusions. Some of these complications include renal
failure, transmission of infectious diseases such as
Hepatitis B and C, HIV, syphilis, transfusion associated
lung injury, immune-modulation, and stroke.2,3,5 Studies
have shown that longer intubation time for patients who
have been given packed red blood cells, has greater risk
of re-intubation and longer postoperative stay.4-6
Therefore, preventing the unnecessary use of blood and
its products would provide substantial benefit to the
patient and improve the overall outcomes.
To minimize the negative impact of blood product use,
current practices include various techniques that have
been adopted to reduce the need for allogeneic
transfusion. These include preoperative autologous
blood transfusion, use of intraoperative antifibrinolytic
agents, intraoperative blood salvage techniques, and
erythropoietin administration, which are beneficial
however, they add a significant cost to an already
expensive procedure and increase the burden on the
patient.7,8
Therefore, to improve the outcomes it would require the
ability to reduce the number of blood products used in
patients, which can be done if we are able to predict who
will and who will not require blood. Being able to
correctly identify patients using a specific criteria, will
assist not only in conservative blood banking and
improved efficiency in blood product utilization but can
also help to reduce related morbidity and mortality in
patients undergoing CABG procedures.
However, of note is the fact that most available data is
from the western hemisphere. Our analysis, therefore,
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aims not just to add pertinent variables that will be
applicable to our South Asian population, but will also
assist in drawing a prediction model that caters best for
patients undergoing CABG in this part of the world.
At the same time, it shall also highlight similarities as
well as differences existing in our prediction tool as
compared to those previously reported.9,10
The main objective of this study was to prepare a clinical
predictive model to determine the need for transfusing
various blood products in CABG procedures in local
population.
METHODOLOGY
A retrospective analytical study was conducted at
Section of Cardiothoracic Surgery, Aga Khan University
Hospital from January 2006 to October 2014. It included
all adult patients aged ≥ 18 years who underwent
isolated on-pump CABG and had elective, urgent or
emergent procedure and excluded all off-pump cases.
The information on blood product type and amount used
that include whole blood, packed red blood cells
(pRBC's), fresh frozen plasma, platelets and
cryoprecipitate were extracted. To ensure reliability in
recording the type of blood product and the amount
being transfused, the hospitals, blood bank records were
consulted in tandem with documented nursing orders
confirming administration. The laboratory data which
had been provided by the Aga Khan University
Laboratory was accounted for and any work-up
performed outside our institute was discounted for to
ensure reliability.
Identification numbers were assigned to each participant
to maintain confidentiality. Any of the participant's details
were not used in these reports. This study was
exempted by Ethical Review Committee (ERC) of the
Aga Khan University Hospital.
The products (singly or in combination) used intra-
operatively, postoperatively or both being allogeneic
transfused to the patient considered blood product use
(dependent variable). These include whole blood,
packed red blood cells (pRBC's), platelets, fresh frozen
plasma (FFP) or cryoprecipitate.
Data was analysed using Statistical Packaging for Social
Sciences (SPSS) version 20. A p-value of < 0.05 was
considered statistically significant. Histograms and
Kolmogorov Normality test was performed to assess the
distribution of the continuous variables. Frequencies and
percentages for categorical variables, mean and
standard deviation for normally distributed continuous
variables, and median and interquartile range for non-
normally distributed continuous variables were calculated. 
Comparison of continuous and categorical variables
between those who received blood products and those
who did not, were evaluated through independent t-test
or chi-square or Fisher's exact test, where appropriate.
Independent predictors of blood transfusion were
identified using univariate analysis and retained in the
multivariable logistic model with an entry criteria of
p < 0.05.
RESULTS
A total of 3,550 patients underwent isolated CABG
during the specified period and 2,001 (56.4%) had
received blood or its components. The participants of
transfused group were elder than the non-transfused
group (mean age 59.8 ±9.4 vs. 56.2 ±9.4 years). Male
proportion in both groups was predominant (74.7 vs.
93.4%, Table I). The non-transfused participants were
more obese compared to transfused participants, BMI
(27.2 ±4.4 vs. 26.3 ±4.2). Diabetes, hypertension,
myocardial infarction and chronic lung and presence of
main left vessel disease of > 50% was more prevalent in
the transfused group (p < 0.05 for all). Ejection fraction
was low and creatinine was high in this group. However,
proportion of family history of coronary artery disease
and tobacco use was high in non-transfused group. Peri-
Hasanat Sharif, Hamza Zaheer Ansari, Awais Ashfaq, Wasiq Faraz Rawasia, Gulshan Bano and Shiraz Hashmi
732 Journal of the College of Physicians and Surgeons Pakistan 2016, Vol. 26 (9): 731-735
Table I: Comparison of patient's demographics, preoperative and
intraoperative characteristics by transfusion and no transfusion,
n=3550.
Variables Transfused Not transfused p-value*
(n=2001) (n=1549)
Age, mean ± SD (years) 59.8 ± 9.4 56.2 ± 9.4 < 0.001
Sex < 0.001
Male, n (%) 1495 (74.7) 1447 (93.4)
Female, n (%) 506 (25.3) 102 (6.6)
BMI (Kg/m2), mean ± SD 26.3 ± 4.2 27.2 ± 4.4 < 0.001
Current tobacco use, n (%) 778 (38.9) 804 (51.9) < 0.001
Diabetes mellitus type-II, n (%) 1104 (55.2) 721 (46.5) < 0.001
Hypertension, n (%) 1522 (76.1) 1065 (68.8) < 0.001
Dyslipidemia, n (%) 1242 (62.1) 949 (61.3) 0.625
Myocardial infarction, n (%) 1109 (55.4) 702 (45.3) < 0.001
Chronic lung disease, n (%) 65 (3.2) 32 (2.1) 0.037
Family history of CAD, n (%) 970 (48.5) 804 (51.9) 0.046
Ejection fraction, mean ± SD 46.7±14.4 50.4±12.4 < 0.001
Creatinine level, mean ± SD 1.2±0.8 1.1±0.7 < 0.001
Left vessel disease > 50%, n (%) 445 (22.2) 229 (14.8) < 0.001
Initial hours. ventilated PO** 13 (7, 20) 8 (6, 14) <0.001
IABP^ insertion, n (%) 255 (12.7) 51 (3.3) < 0.001
Perfusion time (min), mean ± SD 106.8±48.6 98.6±43.3 < 0.001
Cross clamp time (min), mean ± SD 66.2±35.4 62.3±28.1 < 0.001
Lipid lowering therapy, n (%) 1309 (65.4) 962 (62.1) 0.041
Aspirin, n (%) 1576 (78.8) 1205 (77.8) 0.487
Mortality, n (%) 78 (3.9) 14 (0.9) < 0.001
Type of surgery, n (%) < 0.001
Elective# 1369 (68.4) 1270 (82.0)
Urgent† 392 (19.6) 201 (13.0)
Emergent‡ 240 (12.0) 78 (5.0)
* Independent samples t-test for continuous and Pearson Chi-square or Fisher's Exact test
for categorical variables where applied. 
** PO=Post-operative; Median (25th, 75th centile), p value derived from Mann-Whitney-U test.
BMI=Body mass index (kilogram/meter2). 
^ IABP= Intra-Aortic Balloon Pump.
# Any patient operated upon beyond the first 48 hours of being evaluated by the cardiothoracic
services.
† Any patient operated upon between 12-48 hours from the time of admission.
‡ Any patient operated upon up to 12 hours from the time of admission.
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operative variables were statistically different among the
groups. Intra-aortic balloon pump (IABP) requirement,
perfusion and cross-clamp time was significantly high in
transfused subset. The proportion of patient underwent
elective procedure was higher in the non-transfused
compared to the other group (82% vs. 68%);
nevertheless urgent and emergent procedures were
frequent in the transfused group (19.6 vs. 13.0% and
12.0 vs. 5.1% respectively, p < 0.001). More than 62% of
patients were preoperatively using lipid lowering
medicine and more than 77% were on Aspirin therapy in
both groups (Table I). The mortality rate was high in
transfused group (3.9% vs. 0.9%).
More women required transfusions compared to men
included in the study (83% vs. 51%, Table I). Majority of
patients n=1860, (93%) received packed red blood cells
(pRBCs), while 24% received platelets, 21% received
fresh frozen plasma, and only 1.3% received
cryoprecipitate (Table II), while 24% (n=495) were
recipients of more than one blood product.
Several conventional demographic and clinical risk
factors were significantly associated at univariate level
with increased need of transfusion. However, the ones
that predicted best, the risk for blood product use had to
be chosen. Therefore, all the univariate predictors with
(p < 0.05) were taken to generate a multivariate
parsimonious model.
A full multivariate model (Table III), adjusting for
demographics, comorbidities, clinical and perioperative
variables, shows a significant association with trans-
fusions. Age {adjusted OR, (AOR) = 1.03, p < 0.001},
obesity (AOR=1.50, p=0.001), tobacco use (AOR= 1.29,
p=0.001), while male gender emerged as a strongest
predictor, (AOR= 4.51, p < 0.001) in this sample. Among
preoperative comorbidities, diabetes (AOR=1.20,
p=0.016), myocardial infarction (AOR= 1.22, p=0.009),
preoperative creatinine (AOR=1.12, p=0.033), and left
main vessel disease > 50% (AOR= 1.49, p < 0.001) were
independently associated with the transfusion in CABG
patients. Increasing ejection fraction showed a
protective effect (AOR=0.99, p=0.002). Intraoperative
intraaortic balloon pump (IABP) use had two times
increased requirement of blood product use (AOR=
2.14, p < 0.001). A demographic adjusted model {age,
gender, obesity (> 25 BMI Kg/m2) and tobacco use}
showed that those who were operated in urgent and
emergent conditions had greater need of blood
transfusions compared to elective procedures, (AOR:
1.93 and 3.36 respectively, p-value for both categories
was < 0.001).
DISCUSSION
The main aim of this study was to determine the factors
that could predict the need of blood and blood product
transfusions in patients underwent CABG surgery. This
study results showed the transfusion requirement was
up to 56.4% for all the patients which is comparable to
other studies.1,2,10
These results demonstrated that conventional CVD risk
factors such as age, obesity and tobacco use have an
independent association with transfusion.11 Male gender
had the strongest association with the outcomes,
although several studies had reported that females have
greater rates of transfusion in CABG procedures, most
likely because of their smaller circulating blood volume
necessitating increased blood product use.11,12 A
number of comorbidities were independently associated
with transfusion rates. Diabetes shows a significant
effect as this high risk population makes CABG a highly
demanded surgery.13 Previous history of myocardial
infarction, presence of left main vessel disease by
> 50%, and high creatinine level showed independent
Table II: Break-up of type of blood products used, n=2001.
Type of blood products* Number Percentage (%)
Packed RBC 1860 93.0
Fresh Frozen Plasma 422 21.1
Platelets 481 24.0
Cryoprecipitate 27 1.3
*More than one blood product has been transfused
Table III: Crude and adjusted odds ratios and 95% CI for blood and blood product transfused in isolated CABG patients.
Variables Crude OR p-value Adjusted* OR p-value
(95% CI) (95% CI)
Age 1.04 (1.03, 1.05) <0.001 1.03 (1.03, 1.04) <0.001
Gender (male) 4.80 (3.84, 6.01) <0.001 4.51 (3.54, 5.75) <0.001
Current smokers 1.23 (1.08, 1.41) 0.002 1.29 (1.11, 1.50) 0.001
BMI > 25 (Kg/m2) 1.35 (1.18, 1.56) <0.001 1.50 (1.29, 1.75) 0.001
Diabetes mellitus type-II 1.41 (1.24, 1.62) <0.001 1.20 (1.03, 1.39) 0.016
Hypertension 1.44 (1.25, 1.68) <0.001 1.14 (0.97, 1.34) 0.117
Myocardial infarction 1.39 (1.21, 1.59) <0.001 1.22 (1.05, 1.43) 0.009
Ejection fraction 0.98 (0.97, 0.99) <0.001 0.99 (0.98, 1.00) 0.002
Creatinine level 1.25 (1.11, 1.40) <0.001 1.12 (1.01, 1.25) 0.033
Left vessel disease 1.65 (1.38, 1.97) <0.001 1.49 (1.23, 1.81) <0.001
Perfusion time (min) 1.01 (1.00, 1.01) <0.001 1.01 (1.00, 1.01) <0.001
IABP 4.29 (3.15, 5.84) <0.001 2.14 (1.48, 3.08) <0.001
Initial hours ventilated PO 1.05 (1.04, 1.06) <0.001 1.01 (1.00, 1.02) 0.001
*Adjusted for all variables in the model     
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associations as these factors are associated with
significant morbidity and mortality in CABG
procedures.14 Association of hypertension showed a
significant association with the outcome at univariate
level; however, lost its significance after adjustments.
High ejection fraction demonstrated a protective effect
on the outcomes and reduced the transfusion
requirements significantly. Similarly, intra- and
postoperative variables such as IABP, perfusion time,
and initial number of hours ventilated have
demonstrated a significant association with blood
product use. IABP insertion created twice demand of
transfusions. This is due to the greater amount of time
spent by the blood in contact with the artificial surfaces
of the extra corporeal circulation, which in turn
necessitates greater time; and subsequently, the bypass
time itself can lead to an increased risk of transfusion.15
Moreover, prolonged time on the bypass circuit can also
lead to an inflammatory response with the release of
large quantities of cytokines, particularly IL6, IL8, IL10,
coupled with endotoxemia and ischemic reperfusion
injury during and after bypass, all contributing to greater
morbidity and mortality.16 These cytokines along with
oxygen derived free radicals and vessel constricting
factors can all contribute to worsening of cardio-
pulmonary function17 and thus result in prolonged
extubation time, length of CICU stay and chest outputs.
The type of surgery has shown to be a significant
predictor and to be a pertinent variable reported in the
literature.10,18 Urgent and emergent cases were at
greater need of blood transfusion with reference to
elective ones. This can be attributed to the fact that in
emergent cases due to the tenuous clinical status of the
patient, there is frequently inability to wait for reversal of
any anti-platelet agent; which leads to increased blood
loss in the operative field and requires immediate need
of transfusions.
Furthermore, it is also prudent to mention here the
mortality rate in transfused group was thrice (3.9%)
compared to non-transfused group (0.9%). Since the
distribution of elective, urgent and emergent type of
procedure was comparable in mortal cases and no
significant association with the outcome was observed
as other studies have reported;19,20 however, these
numbers cannot be ignored and a large sample size is
required to derive a more direct cause and effect
relationship between transfusion and mortality.
This is the first study to the authors' knowledge that has
developed a predictive model from a large population
that can preoperatively predict the risk of receiving blood
and its products during or after the procedure on an
individual basis. The importance of these tools lies in the
fact that their clinical application will allow for the
effective use of blood products since it will help to stratify
those patients who require blood products from those
who do not, which is a cost effective practice and will
also help prevent the waste of this precious commodity.
It will also facilitate to achieve penultimate goal of better
outcomes for patients, since less and appropriately
directed transfusions will mean a reduction in morbidity
and mortality.
The results should be interpreted cautiously considering
some limitations. Our model is developed at a single
institution; therefore, it could not be generalized to whole
population undergoing CABG surgery. A further multi-
center study is required to get robust inferences. Only
on-pump CABG patients were included; therefore, this
model might not be applicable to the off-pump subsets.
In addition, the effect of unknown confounders or
variables which could not be explored due to
retrospective design, cannot be disregarded completely
due to limitation of the study design. A prospective study
would provide precise and robust estimates.
CONCLUSION
In this study, age, male gender, obesity, tobacco use,
diabetes, myocardial infarction, high creatinine and
urgent and emergent cases were found to be
independent predictors of blood and its components
transfusion in CABG procedures. This model can be
utilised for preoperative risk stratification of patients and
their management to improve the outcomes.
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